Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

NCT04139915 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Phase 3 trial RTB-101-204 study did not meet its primary endpoint

Conditions

Clinically Symptomatic Respiratory Illness

Interventions

DRUG: Dactolisib
DRUG: Placebo

Sponsor

Restorbio Inc.